Structural Heart Devices Market Size

Structural Heart Devices Market size was valued at around USD 11.3 billion in 2023 and is anticipated to register a CAGR of 8.8% between 2024 and 2032. This robust market growth can be attributed to factors such as the growing burden of cardiovascular diseases globally, favorable reimbursement scenarios and the rising preference for minimally invasive procedures.

The primary catalyst for the growth of the market is the increasing incidence of cardiovascular diseases globally. Factors such as aging populations, lifestyle-related diseases, unhealthy diets, genetic factors, and a higher prevalence of chronic conditions like heart valve diseases, cardiomyopathy, and congenital heart diseases contribute to the high prevalence of cardiovascular diseases (CVD).

The aging demographic, particularly in developed regions, is prone to age-related health issues, including heart valve diseases. As the global population ages, there is a parallel increase in the prevalence of coronary heart disease (CHD). According to Centers for Disease Prevention and Control, in 2019, 7.1% of adults aged 45 to 64 years reported having CHD compared with 17.0% of adults aged 65 years and older. These statistics indicate a notable increase in the demand for structural heart devices for individuals suffering from various cardiovascular disorders.

Structural heart devices refer to a category of medical devices designed for the diagnosis and treatment of structural abnormalities within the heart. These devices are utilized to address congenital or acquired conditions that affect the valves, walls, chambers, or vessels of the heart.